Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin Glue to Prevent Bleeding After Gastric ESD in High-Risk Patients
KCT0006000Phase 4Completed
- Sponsor
- GC Biopharma
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of tachosil in gastric cancer (GC), gastric adenoma, sponsored by GC Biopharma. Started Nov 2020; status: completed.
02
Drugs
tachosil
03
Conditions
gastric cancer (GC)gastric adenoma
Beyond the preview
Go deeper on KCT0006000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006000.